Deletions of the 3′ BCR and 5′ ABL regions in patients with Philadelphia-positive chronic myeloid leukemia: A one-step process occurring in about 10% of the cases without any evidence of genetic instability in the target cells

Cancer Genetics and Cytogenetics

Volumn 160, Issue 2, 2005, Pages 184-187

  Fournier, Mickaël ^a   Lacrosse, Stéphanie ^a   Jamar, Mauricette ^a   Bours, Vincent ^a   Herens, Christian ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN;

ADULT; AGED; ARTICLE; BONE MARROW CELL; CHRONIC MYELOID LEUKEMIA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; HUMAN; HUMAN CELL; MALE; MOLECULAR PROBE; PHILADELPHIA CHROMOSOME POSITIVE CELL; PRIORITY JOURNAL; TARGET CELL; GENETICS; GENOMIC INSTABILITY; MIDDLE AGED; MYELOID LEUKEMIA;

FEMALE; FUSION PROTEINS, BCR-ABL; GENOMIC INSTABILITY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MALE; MIDDLE AGED; SEQUENCE DELETION;

EID: 21344453498     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2005.01.002     Document Type: Article

References (15)

1. C. Sawyers Chronic myeloid leukemia N Engl J Med 340 1999 1330 1340
2. J.D. Rowley A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining [Letter] Nature 243 1973 290 293
3. J.V. Melo The molecular biology of chronic myeloid leukemia Leukemia 10 1996 751 756
4. D.C. Tkachuk, C.A. Westbrook, M. Andreeff, T.A. Donlon, M.L. Cleary, K. Suryanarayan, M. Homge, A. Redner, J. Gray, and D. Pinkel Detection of bcr-abl fusion in chronic myelogenous leukemia by in situ hybridization Science 250 1990 559 562
5. Z. Chen, R. Morgan, C.S. Berger, L. Pearce-Birge, J.F. Stone, and A.A. Sandberg Identification of masked and variant Ph (complex type) translocations in CML and classic Ph in AML and ALL by fluorescence in situ hybridization with the use of bcr/abl cosmid probes Cancer Genet Cytogenet 70 1993 103 107
6. G.W. Dewald, C.R. Schad, E.R. Christensen, A.L. Tiede, A.R. Zinsmeister, J.L. Spurbeck, S.N. Thibodeau, and S.M. Jalal The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in CML and ALL Cancer Genet Cytogenet 71 1993 7 14
7. P.B. Sinclair, E.P. Nacheva, M. Leversha, N. Telford, J. Chang, A. Reid, A. Bench, K. Champion, B. Huntly, and A.R. Green Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia Blood 95 2000 738 744
8. C. Herens, F. Tassin, V. Lemaire, Y. Beguin, E. Collard, S. Lampertz, C. Croisiau, M. Lecomte, B. De Prijk, L. Longree, and L. Koulischer Deletion of the 5′-ABL region: a recurrent anomaly detected by fluorescence in situ hybridisation in about 10% of Philadelphia-positive chronic myeloid leukemia patients Br J Haematol 110 2000 214 216
9. B.J. Huntly, A.G. Reid, A.J. Bench, L.J. Campbell, N. Telford, P. Shepherd, J. Szer, H.M. Prince, P. Turner, C. Grace, E.P. Nacheva, and A.R. Green Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia Blood 98 2001 1732 1738
10. G.W. Dewald, W.A. Wyatt, and R.T. Silver Atypical BCR and ABL D-FISH patterns in chronic myeloid leukemia and their possible role in therapy Leuk Lymphoma 34 1999 481 491
11. E. Kolomietz, J. Al-Maghrabi, S. Brennan, J. Karaskova, S. Minkin, J. Lipton, and J.A. Squire Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis Blood 97 2001 3581 3588
12. N. Cohen, G. Rozenfeld-Granot, I. Hardan, F. Brok-Simoni, N. Amariglio, G. Rechavi, and L. Trakhtenbrot Subgroup of patients with Philadelphia-positive chronic myelogenous leukemia characterized by a deletion of 9q proximal to ABL gene: expression profiling, resistance to interferon therapy, and poor prognosis Cancer Genet Cytogenet 128 2001 114 119
13. F. Morel, C. Ka, M.J. Le Bris, A. Herry, P. Morice, P. Bourquard, J.F. Abgrall, C. Berthou, and M. De Braekeleer Deletion of the 5′ abl region in Philadelphia chromosome-positive chronic myeloid leukemia Leukemia 17 2003 473 474
14. C.T. Storlazzi, G. Specchia, L. Anelli, F. Albano, D. Pastore, A. Zagaria, M. Rocchi, and V. Liso Breakpoint characterization of der(9) deletions in chronic myeloid leukemia patients Genes Chromosomes Cancer 35 2002 271 276
15. E. Kolomietz, P. Marrano, K. Yee, B. Thai, I. Braude, A. Kolomietz, K. Chun, S. Minkin, S. Kamel-Ried, M. Minden, and J.A. Squire Quantitative PCR identifies a minimal deleted region of 120 kb extending from the Philadelphia chromosome ABL translocation breakpoint in chronic myeloid leukemia with poor outcome Leukemia 17 2003 1313 1323